Company
DCVC Bio
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Syntax Bio | Series A | 2026-06-22 | |
| Latus Bio | Series A Extension | 2026-05-05 | |
| AgZen | Series B | 2026-03-16 | Lead |
| Nilo Therapeutics | Series A | 2025-10-09 | Lead |
| Grove Biopharma | Series A | 2025-04-24 | Lead |
| Solo Therapeutics | Series A | 2025-04-09 | |
| Newleos Therapeutics | Series A | 2025-02-13 | |
| Umoja Biopharma | Series C | 2025-01-20 | Lead |
| nChroma Bio | Financing | 2024-12-12 | |
| Latus Bio | series a | 2024-05-03 | Lead |
| Frontier Medicines | Series C | 2024-02-25 | |
| Totus Medicines | Series B | 2023-12-17 | Lead |
| CH4 Global | Series B Funding | 2023-08-29 | Lead |
| Solo Therapeutics | Seed Funding | 2023-08-01 | |
| Chroma Medicine | Series B Financing | 2023-03-01 |